Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases

Barrett P. Noel; Terpening Sara J.; Snow Doris; Cobb Ronald R.; Kistner Otfried

首页> 外文期刊>Expert review of vaccines >Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases

【24h】

Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases

机译：VERO细胞技术，用于快速发展灭活的整体病毒疫苗，用于新兴病毒疾病

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Introduction: Rapid development and production of vaccines against emerging diseases requires well established, validated, robust technologies to allow industrial scale production and accelerated licensure of products.

机译：简介：对新兴疾病的疫苗的快速发展和生产需要完善，经验丰富的强大技术，以允许产业规模生产和加速产品许可。

著录项

来源
《Expert review of vaccines》 |2017年第12期|共12页
作者
Barrett P. Noel; Terpening Sara J.; Snow Doris; Cobb Ronald R.; Kistner Otfried;
展开▼
作者单位

Nanotherapeutics Inc 13200 NW Nano Court Alachua FL 32615 USA;

Nanotherapeutics Inc 13200 NW Nano Court Alachua FL 32615 USA;

Nanotherapeutics Inc 13200 NW Nano Court Alachua FL 32615 USA;

Nanotherapeutics Inc 13200 NW Nano Court Alachua FL 32615 USA;

Nanotherapeutics Inc 13200 NW Nano Court Alachua FL 32615 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词
Vero cell; emerging viruses; inactivated whole virus vaccine; rapid development;

机译：Vero细胞;新兴病毒;灭活的整个病毒疫苗;快速发展;

相似文献

外文文献
中文文献
专利

1. Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases [J] . Barrett P. Noel, Terpening Sara J., Snow Doris, Expert review of vaccines . 2017,第7a12期

机译：VERO细胞技术，用于快速发展灭活的整体病毒疫苗，用于新兴病毒疾病
2. Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine. [J] . Lim CK, Takasaki T, Kotaki A, Virology . 2008,第1期

机译：Vero细胞衍生的灭活西尼罗河（WN）疫苗在小鼠中诱导了针对致命WN病毒感染的保护性免疫，并在先前用日本脑炎疫苗免疫的小鼠中显示出促进的中和抗体反应。
3. Safety and immunogenicity of an inactivated whole virus vero cell-derived Ross River virus vaccine: a randomized trial. [J] . Aichinger G., Ehrlich H. J., Aaskov J. G., Vaccine . 2011,第50期

机译：灭活的全病毒Vero细胞来源的罗斯河病毒疫苗的安全性和免疫原性：一项随机试验。
4. VERO SF TECHNOLOGY PLATFORM: STRATEGY FOR RAPID AND EFFECTIVE VACCINE DEVELOPMENT ; FLAVIVIRUS VACCINES CASE STUDY [C] . Anne-marie Beauchard, Nicolas Seve, Jean-Marc Guillaume Conference on vaccine technology VI . 2018

机译：VERO SF技术平台：快速有效开发疫苗的策略；黄病毒疫苗案例研究
5. Characterization of vaccine-associated enhanced respiratory disease (VAERD) in swine administered an inactivated delta-cluster influenza vaccine and challenged with pandemic A/H1N1 virus. [D] . Gauger, Phillip C. 2012

机译：接种灭活的δ-集群流感疫苗并受到大流行A / H1N1病毒攻击的猪中与疫苗相关的增强呼吸道疾病（VAERD）的特征。
6. Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology [O] . Sarah C. Gilbert, George M. Warimwe -1

机译：针对新兴病原体的疫苗的快速开发：复制缺陷的猿猴腺病毒平台技术
7. Development of a Purified, Inactivated, Dengue-2 Virus Vaccine Prototype in Vero Cells: Immunogenicity and Protection in Mice and Rhesus Monkeys [O] . R. Putnak, D. A. Barvir, J. M. Burrous, 1996

机译：在Vero细胞中纯化，灭活的登革热-2病毒疫苗原型：小鼠和恒河猴的免疫原性和保护
8. Development of Safe, Effective Vaccines for Dengue Virus Disease by RecombinantBaculovirus. Subtitle: Development of Safe, Effective Vaccines for Dengue Disease Utilizing Viral Envelope and NSI Glycoproteins Expressed by Recombinant Baculovirus [R] . Lai, C. J. 1991

机译：利用重组杆状病毒开发安全有效的登革病毒疫苗。副标题：利用重组杆状病毒表达的病毒包膜和NsI糖蛋白开发安全有效的登革病疫苗

Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases

摘要

著录项

相似文献

相关主题

期刊订阅